Guy Chamberland MSc, PhD

Dr. Guy Chamberland, M.Sc., Ph.D., Master Herbalist, Chief Executive Officer and Chief Scientific Officer as of October 15, 2018 and was previously as Interim Chief Executive Officer and Chief Scientific Officer since April 2018 and June 2016, respectively. His extensive and broad-based experience in both executive and scientific roles establish Dr. Chamberland as a seasoned and knowledgeable professional in the biopharmaceutical space. Dr. Chamberland has over 22 years of experience in new drug development for the pharmaceutical industry (Canada and USA) with specific expertise in regulatory affairs, and the development and management of clinical research protocols and clinical studies for botanical medicines. He also was a member of the investment committee of the venture capital fund, Fonds Bionvation, for 7 years.

Dr. Chamberland has become a recognized expert in the field of botanical medicine, publishing, lecturing and delivering continuing education workshops to health professionals on the use of plants in the treatment of such areas as pain, anxiety, insomnia, and wound healing. He is the Professor of Botanical Medicine and Principles of clinical research at the Ecole d'Enseignement Superieur de Naturopathie du Quebec (EESNQ) and French language equivalent of the Canadian College of Naturopathic Medicine (CCNNM). He earned a diploma in Proficiency in Herbal Prescription from the Australian College of Phytotherapy, a Certified Herbalist from the Dominion College of Canada and a Master Herbalist diploma from the Dominion College of Canada. Dr. Chamberland received a B.Sc. in Agriculture from McGill University, an M.Sc. in Veterinary anatomy and physiology and a Ph.D. in Biomedical Sciences (toxicology) from the University of Montreal.